Procurement Summary
Country : Estonia
Summary : Immunomodulating and -Stimulating Drugs (L03-L04)
Deadline : 09 Jan 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 111522510
Document Ref. No. : 754332-2024
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : EUR 50000.00
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Purchase of medicines in accordance with what is described in RHAD Annex I Technical description-offer form.
Pegfilgrastim
According to what is described in RHAD Annex I Technical description-offer form
BCG bacteria
Natalizumab
Abatatsept
Vedolizumab
Ocrelizumab
Golimumab
Anakinra
Ustekinumab biosimilar or biooriginal -
Document Type: Contract Notice
Reference Number: 288030
Contract Type: supplies
Estimated Value: 50000.00 - EUR
Authority Type: body-pl
Doc Title: Immunomoduleerivad ja -stimuleerivad ravimid (L03-L04)
Dispatch Date: 2024-12-09
Publish Date: 2024-12-10
Submission Date: 2025-01-09
Documents
Tender Notice